Clinical vitamin B6 analysis: An interlaboratory comparison of pyridoxal 5′-phosphate measurements in serum

Clinical Chemistry

Volumn 51, Issue 7, 2005, Pages 1223-1231

  Rybak, Michael E ^a   Jain, Ram B ^a   Pfeiffer, Christine M ^a,b  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PYRIDOXAL 5 PHOSPHATE; PYRIDOXINE;

ARTICLE; CONSENSUS; CONTROLLED STUDY; ENZYME ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFORMATION PROCESSING; LABORATORY; VITAMIN BLOOD LEVEL; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; DIAGNOSIS, MEASUREMENT AND ANALYSIS; INTERNATIONAL COOPERATION; MULTICENTER STUDY; STANDARD;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; INTERNATIONAL COOPERATION; LABORATORY TECHNIQUES AND PROCEDURES; PYRIDOXAL PHOSPHATE; VITAMIN B 6;

EID: 23444440173     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.050278     Document Type: Article

References (25)

1. Leklem JE. Vitamin B-6: a Status report. J Nutr 1990;120:S1503-7.
2. Bailey AL, Wright AJA, Southern S. High performance liquid chromatography method for the determination of pyridoxal-5-phosphate in human plasma: how appropriate are cut-off values for vitamin B-6 deficiency. Eur J Clin Nutr 1999;53:448-55.
3. Han Q, Xu M, Tang L, Tan X, Tan X, Tan Y, et al. Homogeneous, nonradioactive, enzymatic assay for plasma pyridoxal 5-phosphate. Clin Chem 2002;48:1560-4.
4. Shin YS, Rasshofer R, Friedrich B, Endres W. Pyridoxal-5′-phosphate determination by a sensitive micromethod in human blood, urine and tissues; its relation to cystathioninuria in neuro-blastoma and biliary atresia. Clin Chim Acta 1983;127:77-85.
5. Buehring YSS, Rasshofer R, Endres W. A new enzymatic method for pyridoxal-5-phosphate determination. J Inherit Metab Dis 1981;4:123-4.
6. Phan APH, Ngo TT, Lenhoff HM. Tyrosine decarboxylase spectrophotometric assay and application in determining pyridoxal-5′-phosphate. Appl Biochem Biotechnol 1983;8:127-33.
7. 6: determination of pyridoxal 5′-phosphate and 4-pyridoxic acid in human serum by reversed-phase high-performance liquid chromatography with chlorite postcolumn derivatization. Anal Biochem 2004;333: 336-44.
8. 6 vitamers and pyridoxic acid in plasma: development and evaluation of a high-performance liquid Chromatographic assay. Anal Biochem 2002;305:82-9.
9. Deitrick CL, Katholi RE, Huddleston DJ, Hardiek K, Burrus L. Clinical adaptation of a high-performance liquid Chromatographic method for the assay of pyridoxal 5́-phosphate in human plasma. J Chromatogr B 2001;751:383-7.
10. Bates CJ, Pentieva KD, Matthews N, Macdonald A. A simple, sensitive and reproducible assay for pyridoxal 5′-phosphate and 4-pyridoxic acid in human plasma. Clin Chim Acta 1999;280:101-11.
11. 6 vitamers, especially pyridoxal 5′-phosphate. J Chromatogr A 1996;722:295-301.
12. 6 vitamers and pyridoxic acid in biological samples. J Chromatogr 1992; 578:45-51.
13. 6 nutritional status. J Chromatogr 1985;342:277-84.
14. 6) in whole blood by high-performance liquid chromatography (HPLC). Int J Vitam Nutr Res 1981;51:216-22.
15. Reynolds RD. Nationwide assay of vitamin B-6 in human plasma by different methods [Abstract]. Fed Proc 1983;42:665.
16. Bleie Ø, Refsum H, Ueland PM, Vollset SE, Guttormsen AB, Nexø E, et al. Changes in basal and postmethionine load concentrations of total homocysteine and cystathionine after B vitamin intervention. Am J Clin Nutr 2004;80:641-8.
17. Friso S, Girelli D, Martinelli N, Olivieri O, Lotto V, Bozzini C, et al. Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk. Am J Clin Nutr 2004;79:992-8.
18. Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, et al. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases. Z Kardiol 2004;93:439-53.
19. 6 but not homocyst(e)ine is associated with increased risk of stroke and transient ischemic attack in the era of folic acid grain fortification. Stroke 2003;34:E51-4.
20. Kelly PJ, Kistler JP, Shih VE, Mandell R, Atassi N, Barron M, et al. Inflammation, homocysteine, and vitamin B6 status after ischemic stroke. Stroke 2004;35:12-5.
21. Schwammenthal Y, Tanne D. Homocysteine, B-vitamin supplementation, and stroke prevention: from observational to interventional trials. Lancet Neurol 2004;3:493-5.
22. Sigma-Aldrich. Certificate of analysis, pyridoxal 5′-phosphate. Product no. P9255; lot no. 041K1088. St. Louis, MO: Sigma-Aldrich.
23. Fraser CG, Petersen PH, Libeer J-C, Ricos C. Proposals for setting generally applicable quality goals solely based on biology. Ann Clin Biochem 1997;34:8-12.
24. 6 treatment: a randomized placebo-controlled study. Clin Chem 2003;49:155-61.
25. Millart H, Lamiable D. Determination of pyridoxal 5′-phosphate in human serum by reversed-phase high-performance liquid chromatography combined with spectrofluorimetric detection of 4-pyridoxic acid 5′-phosphate as a derivative. Analyst 1989;114:1225-8.